For adults with T2DM, statin initiation is associated with reductions in all-cause mortality and major CVD risk.

Novo Nordisk announced the availability of Wegovy tablets, the first oral GLP-1 receptor agonist for weight loss and CV risk ...

Among persons with a first positive lung cancer screening result at age 65 years or older, the rate of guideline-concordant ...

Circadian rhythms that are weaker and more fragmented were found to be associated with an increased risk for dementia.

The U.S. Centers for Disease Control and Prevention has reduced the number of diseases protected by routine childhood vaccines from 17 to 11. HealthDay News — Federal health officials have decided to ...

Management of mitochondrial-related heart disease relies on multidisciplinary care and symptom control, as targeted gene-editing therapies are limited.

Review clinical classifications, diagnostic procedures, and management strategies for cardiomyopathy and heart failure in this comprehensive overview.

The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.

The FDA has approved Myqorzo (aficamten) for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).

For Black breast cancer survivors, higher consumption of ultra-processed foods (UPFs) seems to adversely affect breast cancer prognosis.

The FDA approved a new safety warning for Depo-Provera alerting patients to a possible risk for a type of brain tumor called meningioma.

For patients at high cardiovascular risk with overweight/obesity, semaglutide is associated with reduced burden of total hospital admissions.